Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypersensitivity Reaction

  Free Subscription

Articles published in
J Invest Dermatol
    March 2024
  1. ROUSEL J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, et al
    Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
    J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168.
    >> Share

  2. DAS M, Mukherjee S, Geha RS
    Phosphodiesterase 4 Inhibitors, Basophils, and Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 3:S0022-202X(24)00096.
    >> Share

  3. BRAHIMI N, Piguet V
    Autophagy during Severe Acute Respiratory Syndrome Coronavirus 2 Induced Leukocytoclastic Vasculitis: New Insights.
    J Invest Dermatol. 2024;144:441-443.
    >> Share

  4. BETTUZZI T, Hoisnard L, Beytout Q, Ingen-Housz-Oro S, et al
    Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.
    J Invest Dermatol. 2024;144:708-710.
    >> Share

  5. WANG X, Mao D, Jia J, Zhang J, et al
    Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
    J Invest Dermatol. 2024;144:509-519.
    >> Share

    February 2024
  6. GALLO RL, Horswill AR
    Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis.
    J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00002.
    >> Share

  7. BIAZUS SOARES G, Hashimoto T, Yosipovitch G
    Atopic Dermatitis Itch: Scratching for an Explanation.
    J Invest Dermatol. 2024 Feb 15:S0022-202X(24)00091.
    >> Share

  8. WONG C, Tham CY, Yang L, Benton MC, et al
    Nanopore sequencing enables allelic phasing of FLG loss-of-function variants, intragenic copy number variation and methylation status in atopic dermatitis and ichthyosis vulgaris.
    J Invest Dermatol. 2024 Feb 7:S0022-202X(24)00097.
    >> Share

  9. QIAO W, Duan C, Ma J, Hu W, et al
    Costimulatory Molecule CD226 Regulates Atopic Dermatitis in a Mouse Model.
    J Invest Dermatol. 2024 Feb 5:S0022-202X(24)00099.
    >> Share

    January 2024
  10. WANG R, Dai X, Chen W, Wang J, et al
    MMP9 Plays Crucial Role in Inflammation and Itch in Allergic Contact Dermatitis via Regulating TLR2/TLR1 Signaling.
    J Invest Dermatol. 2024 Jan 29:S0022-202X(24)00084.
    >> Share

    December 2023
  11. NAKAI S, Kume M, Matsumura Y, Koguchi-Yoshioka H, et al
    CD69 is indispensable for the development of functional local immune memory in murine contact hypersensitivity.
    J Invest Dermatol. 2023 Dec 20:S0022-202X(23)03190.
    >> Share

  12. SCHULER CF 4TH, Tsoi LC, Billi AC, Harms PW, et al
    Genetic and Immunological Pathogenesis of Atopic Dermatitis.
    J Invest Dermatol. 2023 Dec 11:S0022-202X(23)03057.
    >> Share

  13. GUPTA RK, Fung K, Figueroa DS, Ay F, et al
    Integrative Keratinocyte Responses to TWEAK with IL-13 and IL-22 Reveal Pathogenic Transcriptomes Associated with Atopic Dermatitis.
    J Invest Dermatol. 2023 Dec 8:S0022-202X(23)03128.
    >> Share

    November 2023
  14. TAN L, Chen X, Yan S, Guo A, et al
    WTAP-Mediated N6-Methyladenosine of RNAs Facilitate the Pathophysiology of Atopic Dermatitis.
    J Invest Dermatol. 2023 Nov 27:S0022-202X(23)03113.
    >> Share

  15. ELHAGE KG, Kranyak A, Jin JQ, Haran K, et al
    Mendelian randomization studies in atopic dermatitis: a systematic review.
    J Invest Dermatol. 2023 Nov 15:S0022-202X(23)03052.
    >> Share

  16. KERN C, Ortiz C, Johanis M, Ye M, et al
    Atopic Dermatitis and Cardiovascular Risk in Pediatric Patients: A Systematic Review and Meta-Analysis.
    J Invest Dermatol. 2023 Nov 14:S0022-202X(23)03040.
    >> Share

    October 2023
  17. TAYLOR MA, El Kurdi A, Hailer A, Wang S, et al
    Optimizing single-T cell transcriptomic discrimination of atopic dermatitis versus psoriasis vulgaris.
    J Invest Dermatol. 2023 Oct 23:S0022-202X(23)02973.
    >> Share

  18. AHN JW, Kim SE, Kim DY, Jeong I, et al
    Cav3.2 T-type calcium channel mediates acute itch and contributes to chronic itch and inflammation in experimental atopic dermatitis.
    J Invest Dermatol. 2023 Oct 18:S0022-202X(23)02919.
    >> Share

  19. GRAFF P, Woerz D, Wilzopolski J, Voss A, et al
    EXTRACELLULAR MATRIX REMODELING IN ATOPIC DERMATITIS HARNESSES THE ONSET OF AN ASTHMATIC PHENOTYPE AND IS A POTENTIAL CONTRIBUTOR TO THE ATOPIC MARCH.
    J Invest Dermatol. 2023 Oct 12:S0022-202X(23)02965.
    >> Share

  20. WHEELER JJ, Williams N, Yu J, Mishra SK, et al
    Brain Natriuretic Peptide Exerts Inflammation and Peripheral Itch in a Mouse Model of Atopic Dermatitis.
    J Invest Dermatol. 2023 Oct 11:S0022-202X(23)02922.
    >> Share

  21. TAKAHASHI K, Miyake K, Ito J, Shimamura H, et al
    Topical application of a PDE4 inhibitor ameliorates atopic dermatitis through inhibition of basophil IL-4 production.
    J Invest Dermatol. 2023 Oct 10:S0022-202X(23)02920.
    >> Share

    September 2023
  22. KIM M, Renert-Yuval Y, Stepensky P, Even-Or E, et al
    Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines.
    J Invest Dermatol. 2023 Sep 22:S0022-202X(23)02595.
    >> Share

  23. MIYAGAWA F, Ozato K, Tagaya Y, Asada H, et al
    Type I Interferon derived from Ly6Chi monocytes suppresses type 2 inflammation in murine model of atopic dermatitis.
    J Invest Dermatol. 2023 Sep 20:S0022-202X(23)02588.
    >> Share

    August 2023
  24. SOCKLER PG, Hooper SR, Kartawira K, Wan J, et al
    Cognitive function and academic achievement in children with early childhood atopic dermatitis.
    J Invest Dermatol. 2023 Aug 14:S0022-202X(23)02497.
    >> Share

  25. GAWAZ A, Schindler M, Hagelauer E, Blanchard G, et al
    SARS-CoV-2 induced vasculitic skin lesions are associated with massive spike protein depositions in autophagosomes.
    J Invest Dermatol. 2023 Aug 12:S0022-202X(23)02501.
    >> Share

  26. MARGOLIS DJ, Chiesa Fuxench ZC, Hoffstad OJ, Grice EA, et al
    Pregnant females with atopic dermatitis are more likely to be colonized with group B streptococci.
    J Invest Dermatol. 2023 Aug 4:S0022-202X(23)02491.
    >> Share

    July 2023
  27. JIA T, Che D, Zheng Y, Zhang H, et al
    Mast cells Initiate Type 2 Inflammation via Tryptase Released by MRGPRX2/MrgprB2 Activation in Atopic Dermatitis.
    J Invest Dermatol. 2023 Jul 21:S0022-202X(23)02422.
    >> Share

  28. KIM JE, Lee J, Huh YJ, Kim K, et al
    Genomic profiling of the overlap phenotype between psoriasis and atopic dermatitis.
    J Invest Dermatol. 2023 Jul 5:S0022-202X(23)02401.
    >> Share

    June 2023
  29. MORTLOCK RD, Ma EC, Cohen JM, Damsky W, et al
    Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.
    J Invest Dermatol. 2023 Jun 20:S0022-202X(23)01992.
    >> Share

  30. ZHOU Y, Xu X, Liu Y, Wang A, et al
    Heterogeneous regulation of Staphylococcus aureus by different Staphylococcus epidermidis agr types in atopic dermatitis.
    J Invest Dermatol. 2023 Jun 2:S0022-202X(23)02138.
    >> Share

  31. SCHWARZ A, Philippsen R, Schwarz T
    Mouse Models of Allergic Contact Dermatitis: Practical Aspects.
    J Invest Dermatol. 2023;143:888-892.
    >> Share

    May 2023
  32. YU J, Song P, Bai Y, Dang E, et al
    CD36-SREBP1 axis mediates thymic stromal lymphopoietin production in obesity-exacerbated atopic dermatitis.
    J Invest Dermatol. 2023 May 18:S0022-202X(23)02070.
    >> Share

  33. ZHANG W, Chen W, Shan C, Wang R, et al
    IL-13 Activates Cutaneous Schwann Cells to Promote CCL7-dependent Pruritic Signaling in Atopic Dermatitis.
    J Invest Dermatol. 2023 May 13:S0022-202X(23)02061.
    >> Share

  34. SUN L, Wang Z, Liu T, Zhao Q, et al
    TAP2 Drives HLA-B *13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity.
    J Invest Dermatol. 2023;143:722-730.
    >> Share

    April 2023
  35. CHEN CB, Wang CW, Chung WH
    TNF-alpha Blockade Inhibits Matrix Metalloproteinase 9-Mediated Collagenase Activity in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2023 Apr 22:S0022-202X(23)01837.
    >> Share

  36. MINZAGHI D, Pavel P, Kremslehner C, Gruber F, et al
    Excessive production of hydrogen peroxide in mitochondria contributes to atopic dermatitis.
    J Invest Dermatol. 2023 Apr 19:S0022-202X(23)01987.
    >> Share

  37. HALLING AS, Fritz BG, Gerner T, Rinnov MR, et al
    Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children.
    J Invest Dermatol. 2023 Apr 19:S0022-202X(23)01989.
    >> Share

  38. AGELOPOULOS K, Stander S
    Reply to: Neuroanatomic signatures in brachioradial pruritus, chronic prurigo and atopic dermatitis.
    J Invest Dermatol. 2023 Apr 8:S0022-202X(23)01974.
    >> Share

  39. WALLENGREN J
    Neuroanatomic Signatures in Brachioradial Pruritus, Chronic Prurigo, and Atopic Dermatitis.
    J Invest Dermatol. 2023 Apr 7:S0022-202X(23)00167.
    >> Share

  40. OKAMOTO M, Omori-Miyake M, Kuwahara M, Okabe M, et al
    The inhibition of glycolysis in T cells by a Jak inhibitor ameliorates the pathogenesis of allergic contact dermatitis in mice.
    J Invest Dermatol. 2023 Apr 5:S0022-202X(23)01957.
    >> Share

    March 2023
  41. BANGERT C, Loesche C, Skvara H, Folster-Holst R, et al
    IgE Depletion With Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis.
    J Invest Dermatol. 2023 Mar 31:S0022-202X(23)01942.
    >> Share

  42. DEKKERS C, van der Wal MM, El Amrani M, van Luin M, et al
    Biological tipping point in atopic dermatitis patients treated with different dosing intervals of dupilumab.
    J Invest Dermatol. 2023 Mar 28:S0022-202X(23)01943.
    >> Share

  43. HUANG LY, Li ST, Lin SC, Kao CH, et al
    Gasdermin A is Required for Epidermal Cornification during Skin Barrier Regeneration and in an Atopic Dermatitis-like Model.
    J Invest Dermatol. 2023 Mar 23:S0022-202X(23)01938.
    >> Share

  44. ZHOU H, Tan X, Chen G, Liu X, et al
    Extracellular vesicles of commensal skin microbiota alleviate cutaneous inflammation in atopic dermatitis mouse model by reestablishing skin homeostasis.
    J Invest Dermatol. 2023 Mar 10:S0022-202X(23)00169.
    >> Share

    February 2023
  45. IRIKI H, Takahashi H, Amagai M
    Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases.
    J Invest Dermatol. 2023 Feb 24:S0022-202X(22)02836.
    >> Share

  46. GREENFIELD DA, Feizpour A, Evans CL
    Quantifying Inflammatory Response and Drug-Aided Resolution in an Atopic Dermatitis model with Deep Learning.
    J Invest Dermatol. 2023 Feb 17:S0022-202X(23)00094.
    >> Share

  47. AL-JANABI A, Eyre S, Foulkes AC, Khan AR, et al
    Atopic polygenic risk score is associated with paradoxical eczema developing in psoriasis patients treated with biologics.
    J Invest Dermatol. 2023 Feb 15:S0022-202X(23)00077.
    >> Share

    January 2023
  48. VAHER H, Kingo K, Kolberg P, Pook M, et al
    Skin colonization with S. aureus can lead to increased NLRP1 inflammasome activation in patients with atopic dermatitis.
    J Invest Dermatol. 2023 Jan 31:S0022-202X(23)00066.
    >> Share

  49. PADHI A, Rekha RS, Benrejdal L, Grundeken ME, et al
    Baricitinib blocks cytokine mediated downregulation of PAD1 in human keratinocytes: a possible molecular link to the effects of JAK-inhibitors in atopic dermatitis.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(23)00001.
    >> Share

  50. MAKI-OPAS I, Hamalainen M, Moilanen LJ, Sood H, et al
    Transient Receptor Potential Ankyrin 1 (TRPA1) Mediates Contact Hypersensitivity Induced by 2,4-dinitrochlorobenzene (DNCB).
    J Invest Dermatol. 2023 Jan 9:S0022-202X(23)00008.
    >> Share

  51. GROLLEAU C, Calugareanu A, Demouche S, Nosbaum A, et al
    IL-4/IL-13 inhibitors for atopic dermatitis induce psoriatic rash transcriptionally close to pustular psoriasis.
    J Invest Dermatol. 2023 Jan 4:S0022-202X(22)02817.
    >> Share

  52. ZHANG L, Qiu L, Wu J, Qi Y, et al
    GWAS of Chronic Spontaneous Urticaria Reveals Genetic Overlap with Autoimmune Diseases, Not Atopic Diseases.
    J Invest Dermatol. 2023;143:67-77.
    >> Share

    December 2022
  53. OLSSON-BROWN A, Yip V, Ogiji ED, Jolly C, et al
    TNF-alpha mediated keratinocyte expression and release of matrix metalloproteinase 9: putative mechanism of pathogenesis in Stevens-Johnson syndrome/ toxic epidermal necrolysis.
    J Invest Dermatol. 2022 Dec 26:S0022-202X(22)02898.
    >> Share

  54. CHIMBETETE T, Buck C, Choshi P, Selim R, et al
    HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity.
    J Invest Dermatol. 2022 Dec 20:S0022-202X(22)02769.
    >> Share

  55. DA M, Chen L, Enk A, Mahnke K, et al
    Tolerance to DNFB-induced contact hypersensitivity is mediated by CD73 expressing tissue-homing regulatory T cells.
    J Invest Dermatol. 2022 Dec 17:S0022-202X(22)02887.
    >> Share

  56. KARMON M, Kopel E, Barzilai A, Geva P, et al
    Altered RNA editing in Atopic Dermatitis highlights the role of dsRNA for immune surveillance.
    J Invest Dermatol. 2022 Dec 8:S0022-202X(22)02837.
    >> Share

  57. HU T, Todberg T, Ewald DA, Hoof I, et al
    Assessment of Spatial and Temporal Variation in the Skin Transcriptome of Atopic Dermatitis by Use of 1.5 mm Mini Punch Biopsies.
    J Invest Dermatol. 2022 Dec 7:S0022-202X(22)02657.
    >> Share

  58. GONZALEZ JR, Celli A, Weckel A, Dhariwala MO, et al
    Filaggrin deficiency in mice alters the early life CD4(+) T cell response to skin commensal bacteria.
    J Invest Dermatol. 2022 Dec 7:S0022-202X(22)02822.
    >> Share

    November 2022
  59. FANG X, Li M, He C, Liu Q, et al
    Plasma-Derived Exosomes in Chronic Spontaneous Urticaria Induce the Production of Mediators by Human Mast Cells.
    J Invest Dermatol. 2022;142:2998-3008.
    >> Share

    October 2022
  60. YEO H, Ahn SS, Jung E, Lim Y, et al
    Transcription Factor EGR1 Regulates the Expression of the Clock Gene PER2 under IL-4 Stimulation in Human Keratinocytes.
    J Invest Dermatol. 2022;142:2677-2686.
    >> Share

    September 2022
  61. SILVA-VILCHES C, Bolduan V, Alabdullah M, Steinbrink K, et al
    Topical application of adenosine A2-type receptor agonists prevents contact hypersensitivity reactions in mice by affecting skin dendritic cells.
    J Invest Dermatol. 2022 Sep 26. pii: S0022-202X(22)01908.
    >> Share

  62. WU H, Ke X, Huang W, Shi W, et al
    Multi-Tissue Integrative Analysis Identifies Susceptibility Genes for Atopic Dermatitis.
    J Invest Dermatol. 2022 Sep 22. pii: S0022-202X(22)01940.
    >> Share

  63. KOCH M, Kockmann T, Rodriguez E, Wehkamp U, et al
    Quantitative proteomics identifies reduced NRF2 activity and mitochondrial dysfunction in Atopic Dermatitis.
    J Invest Dermatol. 2022 Sep 12. pii: S0022-202X(22)01904.
    >> Share

  64. AGELOPOULOS K, Renkhold L, Wiegmann H, Dugas M, et al
    Transcriptomic, epigenomic and neuro-anatomic signatures differ in chronic prurigo, atopic dermatitis and brachioradial pruritus.
    J Invest Dermatol. 2022 Sep 5. pii: S0022-202X(22)01895.
    >> Share

    August 2022
  65. KIM JH, Ahn S, Ghosh P, Rhee DK, et al
    Immunization with a Pneumococcal pep27 Mutant Strain Alleviates Atopic Dermatitis by Upregulation of Regulatory T Cell Activity and Epithelial Barrier Function and Suppressing TSLP Expression.
    J Invest Dermatol. 2022 Aug 18. pii: S0022-202X(22)01779.
    >> Share

  66. ALMOUGHRABIE S, Gallo RL
    Interdependence of Sebaceous Lipids and the Microbiome in Atopic Dermatitis.
    J Invest Dermatol. 2022 Aug 16. pii: S0022-202X(22)01679.
    >> Share

  67. DAI X, Muto J, Shiraishi K, Utsunomiya R, et al
    TSLP Impairs Epidermal Barrier Integrity by Stimulating the Formation of Nuclear IL-33/Phosphorylated STAT3 Complex in Human Keratinocytes.
    J Invest Dermatol. 2022;142:2100-2108.
    >> Share

    July 2022
  68. SHO Y, Sakai T, Sato T, Sonezaki M, et al
    Stratum corneum ceramide profiles provide reliable indicators of remission and potential flares in atopic dermatitis.
    J Invest Dermatol. 2022 Jul 20. pii: S0022-202X(22)01664.
    >> Share

  69. OLYDAM JI, de Wijs LEM, Dik WA, Ropke MA, et al
    EASI p-EASI: predicting disease severity in atopic dermatitis patients treated with tralokinumab.
    J Invest Dermatol. 2022 Jul 14. pii: S0022-202X(22)01649.
    >> Share

  70. HIKINO K, Tanaka N, Koido M, Tomizuka K, et al
    Genetic architectures underlie onset age of atopic dermatitis.
    J Invest Dermatol. 2022 Jul 13. pii: S0022-202X(22)01662.
    >> Share

    June 2022
  71. MORIMOTO A, Fukuda K, Ito Y, Tahara U, et al
    Microbiota-Independent Spontaneous Dermatitis Associated With Increased Sebaceous Lipid Production in Tmem79-Deficient Mice.
    J Invest Dermatol. 2022 Jun 22. pii: S0022-202X(22)01588.
    >> Share

  72. XUE S, Zhu R, Chen W, Yang H, et al
    Inhibiting Keratinocyte-derived STAT6 Improved Atopic Dermatitis in Mice.
    J Invest Dermatol. 2022 Jun 8. pii: S0022-202X(22)01530.
    >> Share

  73. PORTER M, Choshi P, Pedretti S, Chimbetete T, et al
    IFN-gamma ELISpot in Severe Cutaneous Adverse Reactions to First-line Anti-tuberculosis Drugs in an HIV Endemic Setting.
    J Invest Dermatol. 2022 Jun 1. pii: S0022-202X(22)01500.
    >> Share

    May 2022
  74. LE TK, Brown I, Goldberg R, Taylor MT, et al
    Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: an Observational, Pharmacovigilance Study.
    J Invest Dermatol. 2022 May 18. pii: S0022-202X(22)00389.
    >> Share

  75. CHEN Y, Chen W
    Genome-wide integration of genetic and genomic studies of atopic dermatitis: Insights into genetic architecture and pathogenesis.
    J Invest Dermatol. 2022 May 13. pii: S0022-202X(22)00390.
    >> Share

    April 2022
  76. WANG J, Pajulas A, Fu Y, Adom D, et al
    gammadelta T cell-mediated Wound Healing is Diminished by Allergic Skin Inflammation.
    J Invest Dermatol. 2022 Apr 1. pii: S0022-202X(22)00255.
    >> Share

  77. BROWN SJ
    Atopic Eczema: How Genetic Studies Can Contribute to the Understanding of this Complex Trait.
    J Invest Dermatol. 2022;142:1015-1019.
    >> Share

    March 2022
  78. LEMAN G, Pavel P, Hermann M, Crumrine D, et al
    Mitochondrial activity is up-regulated in nonlesional atopic dermatitis and amenable to therapeutic intervention.
    J Invest Dermatol. 2022 Mar 24. pii: S0022-202X(22)00205.
    >> Share

  79. WOODS K, Cait A, Gell K, Naidoo K, et al
    Goat milk-derived lipids restrain NKT cell-dependent eosinophilic inflammation in a murine model of atopic dermatitis.
    J Invest Dermatol. 2022 Mar 14. pii: S0022-202X(22)00200.
    >> Share

  80. SUTARIA N, Alphonse MP, Roh YS, Choi J, et al
    Cutaneous transcriptomics identifies fibroproliferative and neurovascular gene dysregulation in prurigo nodularis compared to psoriasis and atopic dermatitis.
    J Invest Dermatol. 2022 Mar 4. pii: S0022-202X(22)00175.
    >> Share

  81. GONZALEZ-PEREZ R, Poza-Guedes P, Pineda F, Castillo M, et al
    Atopic Dermatitis and Frequency of Der p 11 Binding as a Major Allergen Revisited.
    J Invest Dermatol. 2022;142.
    >> Share

  82. GATTINGER P, Huang HJ, Valenta R, Vrtala S, et al
    Response to Gonzalez-Perez et al.
    J Invest Dermatol. 2022;142.
    >> Share

  83. MIZUKAWA Y, Aoyama Y, Takahashi H, Takahashi R, et al
    Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification.
    J Invest Dermatol. 2022;142.
    >> Share

    February 2022
  84. PADHI A, Srivastava A, Ramesh A, Ehrstrom M, et al
    IL-22 Downregulates Peptidylarginine Deiminase-1 in Human Keratinocytes: Adding Another Piece to the IL-22 Puzzle in Epidermal Barrier Formation.
    J Invest Dermatol. 2022;142:333-342.
    >> Share

    January 2022
  85. MISHRA SK
    The Role of CNTNAP2 in Itch Sensation.
    J Invest Dermatol. 2022;142:251-253.
    >> Share

  86. DAI X, Shiraishi K, Muto J, Utsunomiya R, et al
    Nuclear IL-33 Plays an Important Role in IL-31Mediated Downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and Activator of Transcription 3 Activation in Human Keratinocytes.
    J Invest Dermatol. 2022;142:136-144.
    >> Share

    November 2021
  87. ZHANG Z, Elder JT
    Making Lemonade: Putting the Wisdom of the Genome to Work in Atopic Dermatitis.
    J Invest Dermatol. 2021;141:2561-2564.
    >> Share

  88. MIZAWA M, Matsumura K, Hamazaki K, Furukawa F, et al
    Infantile Hemangioma and the Risk Factors in a Japanese Population: A Nationwide Longitudinal Study-The Japan Environment and Children's Study.
    J Invest Dermatol. 2021;141:2745-2748.
    >> Share

  89. DAI X, Utsunomiya R, Shiraishi K, Mori H, et al
    Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes.
    J Invest Dermatol. 2021;141:2646-2655.
    >> Share

  90. SHIDO K, Kojima K, Shirota M, Yamasaki K, et al
    GWAS Identified IL4R and the Major Histocompatibility Complex Region as the Associated Loci of Total Serum IgE Levels in 9,260 Japanese Individuals.
    J Invest Dermatol. 2021;141:2749-2752.
    >> Share

    October 2021
  91. KLOPOT A, Baida G, Kel A, Tsoi LC, et al
    Transcriptome analysis reveals intrinsic pro-inflammatory signaling in healthy African American skin.
    J Invest Dermatol. 2021 Oct 29. pii: S0022-202X(21)02400.
    >> Share

  92. CASTILLO R, Subudhi I, Naik S
    Fanning the Flames: IRAK2 Signaling in Differentiated Epithelium Potentiates Skin Inflammation.
    J Invest Dermatol. 2021;141:2325-2327.
    >> Share

  93. SHAO S, Tsoi LC, Swindell WR, Chen J, et al
    IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses.
    J Invest Dermatol. 2021;141:2436-2448.
    >> Share

    September 2021
  94. HAILFINGER S, Schulze-Osthoff K
    Impaired Autophagy in Psoriasis and Atopic Dermatitis: A New Therapeutic Target?
    J Invest Dermatol. 2021 Sep 23. pii: S0022-202X(21)01409.
    >> Share

    July 2021
  95. TANAKA R, Ichimura Y, Kubota N, Saito A, et al
    Differential involvement of programmed cell death ligands in skin immune responses.
    J Invest Dermatol. 2021 Jul 23. pii: S0022-202X(21)01458.
    >> Share

  96. ZHU Y, Mitra N, Feng Y, Tishkoff S, et al
    FLG Variation Differs between European Americans and African Americans.
    J Invest Dermatol. 2021;141:1855-1857.
    >> Share

  97. LYUBCHENKO T, Collins HK, Vang KA, Leung DYM, et al
    SMOC1 and IL-4 and IL-13 Cytokines Interfere with Ca(2+) Mobilization in Primary Human Keratinocytes.
    J Invest Dermatol. 2021;141:1792-1801.
    >> Share

    June 2021
  98. VAN DEN BOGAARD EH, Perdew GH
    The Enigma of AHR Activation in the Skin: Interplay among Ligands, Metabolism, and Bioavailability.
    J Invest Dermatol. 2021;141:1385-1388.
    >> Share

  99. DE GROOT R, Bosma AL, Cornet R, Spuls PI, et al
    The Selection Process for a Web-Based Application to Measure Patient-Reported Outcomes Following the Example of the TREAT NL Registry.
    J Invest Dermatol. 2021;141:1592-1595.
    >> Share

    May 2021
  100. NOE MH
    Understanding Epidermal Necrolysis after the Initial Hospitalization.
    J Invest Dermatol. 2021;141:1139-1140.
    >> Share

  101. WANG Z, Yoo YJ, De La Torre R, Topham C, et al
    Inverse Correlation of TRIM32 and Protein Kinase C zeta in T Helper Type 2-Biased Inflammation.
    J Invest Dermatol. 2021;141:1297-1307.
    >> Share

    April 2021
  102. BRAUWEILER AM, Leung DYM, Goleva E
    The Transcription Factor p63 Is a Direct Effector of IL-4- and IL-13-Mediated Repression of Keratinocyte Differentiation.
    J Invest Dermatol. 2021;141:770-778.
    >> Share

  103. PENG W, Kwiek B, Yu C, Garbi N, et al
    Infiltration and Clustering of Major Histocompatibility Complex II(+) Antigen-Presenting Cells in the Skin of Patients with Atopic Dermatitis.
    J Invest Dermatol. 2021;141:939-942.
    >> Share

    March 2021
  104. NOVACKOVA A, Sagrafena I, Pullmannova P, Paraskevopoulos G, et al
    Acidic pH is Required for the Multilamellar Assembly of Skin Barrier Lipids in Vitro.
    J Invest Dermatol. 2021 Mar 3. pii: S0022-202X(21)00238.
    >> Share

  105. THOMAS J, Wang R, Batra R, Bohner A, et al
    CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis.
    J Invest Dermatol. 2021;141:681-685.
    >> Share

  106. HART PH, Norval M
    The Multiple Roles of Urocanic Acid in Health and Disease.
    J Invest Dermatol. 2021;141:496-502.
    >> Share

  107. SHTESSEL M, Limjunyawong N, Oliver ET, Chichester K, et al
    MRGPRX2 Activation Causes Increased Skin Reactivity in Patients with Chronic Spontaneous Urticaria.
    J Invest Dermatol. 2021;141:678-681.
    >> Share

    February 2021
  108. ABERER E, Sperr WR, Bretterklieber A, Avian A, et al
    Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM).
    J Invest Dermatol. 2021 Feb 10. pii: S0022-202X(21)00102.
    >> Share

  109. YEO H, Ahn SS, Lee JY, Jung E, et al
    Disrupting the DNA binding of EGR-1 with a small-molecule inhibitor ameliorates 2,4-dinitrochlorobenzene-induced skin inflammation.
    J Invest Dermatol. 2021 Feb 3. pii: S0022-202X(21)00082.
    >> Share

  110. BERNA R, Mitra N, Lou C, Wan J, et al
    TSLP and IL-7R Variants Are Associated with Persistent Atopic Dermatitis.
    J Invest Dermatol. 2021;141:446-450.
    >> Share

  111. MIRANDA E, Roberts J, Novick S, Lapointe JM, et al
    Immunohistochemical Characterization of the IL-13:IL-4 Receptor alpha Axis in the Skin of Adult Patients with Moderate to Severe Atopic Dermatitis and Healthy Controls.
    J Invest Dermatol. 2021;141:440-443.
    >> Share

    December 2020
  112. CHU MT, Wang CW, Chang WC, Chen CB, et al
    Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions.
    J Invest Dermatol. 2020 Dec 16. pii: S0022-202X(20)32398.
    >> Share

    November 2020
  113. MARXER CA, Frey N, Bodmer M, Bircher A, et al
    Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A UK-based Cohort Study.
    J Invest Dermatol. 2020 Nov 19. pii: S0022-202X(20)32292.
    >> Share

  114. BOJANOWSKI K, Swindell WR, Cantor S, Chaudhuri RK, et al
    Isosorbide di-(linoleate/oleate) stimulates pro-differentiation gene expression to restore the epidermal barrier and improve skin hydration.
    J Invest Dermatol. 2020 Nov 9. pii: S0022-202X(20)32282.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016